CDMO
With its new cGMP facility in Zurich, Siegfried subsidiary Dinamiqs has reached an important milestone in the manufacture of viral vectors. The company combines research, development, and clinical and commercial production under one roof, thereby significantly expanding its capacities. At the same time, Dinamiqs is entering into a collaboration with Seal Therapeutics to advance the development of...
Fette Compacting and CDMO "CMIC CMO USA" are entering into a strategic partnership. The collaboration is an important step in the implementation of Fette Compacting's new strategy, “Together - from lab to production.” It strengthens the company's position as a comprehensive process partner. The focus of the collaboration is the integration of the FE CPS continuous direct compression system with an...
Touchlight, a Contract Development and Manufacturing Organisation (CDMO), has announced that its Hampton, UK facility has achieved GMP certification. This makes Touchlight the first synthetic DNA manufacturer in the world to receive regulatory approval for the manufacture of Active Pharmaceutical Ingredient (API). This places the company in a unique position to support its growing customer base in...
Vetter, a global pharmaceutical service provider, is expanding its management team. From January 2025, Thomas Otto and Peter Sölkner will join Henryk Badack, Titus Ottinger and Carsten Press in managing the family-owned company. By expanding its management team, the independent CDMO for the manufacturing of complex injectable drugs is ensuring its sustainable growth. “We at Vetter are committed to...
Vetter is investing in the expansion of its production capacities in Germany and the USA. The pharmaceutical service provider will relocate its site for development services within the USA and continue to expand there. At the same time, in addition to the ongoing capacity expansions in Ravensburg and Langenargen, Vetter is planning to establish a further site in Saarlouis, Saarland, for the...
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has been awarded the Frost & Sullivan’s 2023 Global Customer Value Leadership Award in the aseptic fill-and-finish market for the company’s high performance for its customers. The award, presented annually by the international growth strategy consulting firm, focuses on both business and customer impact along with...
Vetter, a globally leading contract development and manufacturing organization (CDMO), announced the commissioning of a new warehouse designed to help meet increasing customer market supply demands. With a total investment of approx. 20 million euros, the new fully automated building provides storage space for materials with high-stock turnover rates such as packaging components and thus...
With the realization of the first successful customer fills, Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has reached another milestone at its new clinical manufacturing facility in Rankweil, Austria. Further batches are already planned, and more customer projects are in the business pipeline. In addition, the site is being expanded to optimize processes and...
For the third year in a row, Vetter, a globally leading contract development and manufacturing organization (CDMO), has won the Best Managed Companies Award. With this three-win feat, the pharmaceutical service provider has once again demonstrated why it is considered one of the industry leaders. The awards committee selected the CDMO based on a variety of initiatives such as its culture of...
For the second time in a row, Vetter, a global leading contract development and manufacturing organization (CDMO), has won the „Axia Best Managed Companies Award“. The pharmaceutical service provider was again honored for its clear vision, innovative approaches, sustainable management culture and sound financial management. Every year, Deloitte Private, the prominent German business journal...
